Evaluation of the TMJ by means of Clinical TMD Examination and MRI Diagnostics in Patients with Rheumatoid Arthritis

Figure 1

Percentage distribution of anamnestic () and clinical dysfunction indices () by Helkimo in test subjects of the control group (group N, subjects) and the group of patients with rheumatoid arthritis (group RA, patients). Ai0 (subjectively symptom-free), AiI (mild symptoms), AiII (severe symptoms), Di0 (clinically symptom-free), DiI (mild symptoms), DiII (moderate symptoms), and DiIII (severe symptoms).